Abstract
Verapamil block of Cav1.2 is frequency-dependent and potentiated by Ca2+. We examined the molecular determinants of these characteristics using mutations that effect Ca2+ interactions with Cav1.2. Mutant and wild-type Cav1.2 channels were transiently expressed in tsA 201 cells with β1b and α2δ subunits. The four conserved glutamates that compose the Ca2+ selectivity filter in Cav1.2 were mutated to Gln (E363Q, E709Q, E1118Q, E1419Q) and the adjacent conserved threonine in each domain was mutated to Ala (T361A, T707A, T1116A, T1417A). The L-type-specific residues in the domain III pore region (F1117G) and the C-terminal tail (I1627A) were also mutated and assayed for block by verapamil using whole-cell voltage-clamp recordings in 10 mM Ba2+ or 10 mM Ca2+. In Ba2+, none of the pore-region mutations reduced the fraction of current blocked by 30 μM verapamil at 0.05 Hz stimulation. However, all of the pore-region mutations abolished Ca2+ potentiation of verapamil block at 0.05 Hz. The T1116A, F1117G, E1118Q, and E1419Q mutations all significantly reduced frequency-dependent verapamil block (1-Hz stimulation) in both Ba2+ and Ca2+. The I1627A mutation, which disrupts Ca2+-dependent inactivation, increased the fraction of closed channels blocked by 30 μM verapamil in Ba2+ but did not affect frequency-dependent block in Ba2+ or Ca2+. Our data suggest that the pore region of domain III may contribute to a high affinity verapamil binding site accessed during 1-Hz stimulation and that Ca2+ binding to multiple sites may be required for potentiation of verapamil block of closed channels.
- Received March 29, 2004.
- Accepted July 28, 2004.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|